Sponsorship and Funding


The International League Against Epilepsy is a medical association comprised of physicians, basic scientists and other health care professionals. Our mission is to provide members with the educational and research resources that are essential in understanding, diagnosing and treating persons with epilepsy. We accept sponsorship from pharmaceutical companies, medical product companies and other health related organizations, provided sponsorship adheres to ILAE rules in terms of transparency and ethical code.

Through our international and regional congresses, workshops and other programs, sponsors are provided with the opportunity to:

  • Present new clinical data and product information to a targeted customer base
  • Support epilepsy education through unrestricted educational grants
  • Demonstrate commitment to improving the quality of life for people with epilepsy

2022 Funding Sources


Industry related income is 36% of overall income, and non-industry related income is 64%. The largest contribution by one particular company is 7.7% of overall income.

2022 Sponsors

  • Ad-Tech Medical Instrument Corporation
  • Angelini Pharma
  • BESA GmbH
  • Biocodex
  • BioMarin Oharmaceutical Inc
  • Brainlab
  • Compumedics  
  • Danone   
  • Deep Breath Intelligence AG
  • Desitin Arzneimittel GmbH
  • DIXI medical
  • Eisai  
  • Epilog NV
  • G.S.A.R. Marketing, SL
  • HempMeds Mexico SA de CV
  • Instrumentacion SA
  • Jazz Pharmaceuticals
  • John Libbey Eurotext
  • Labortorios Biopas SA
  • LivaNova   
  • Medtronic
  • Micromed
  • Natus Medical Incorporated
  • Neurelis, Inc.
  • Neuro Events Labs
  • Neuroventis BV
  • Neurovirtual USA Inc
  • NightWatch
  • Nihon Kohden
  • Orion Pharma
  • Persyst Development Corporation
  • PTC Therapeutics
  • Ripple
  • RP Médicas SA
  • Savoy Foundation
  • Seer Medical
  • Takeda Pharmaceuticals
  • Tecnofarma Colombia SAS
  • UCB Biopharma SRL
  • UNEEG Medical A/S
  • vCreate Ltd
  • WamaPharma SAS
  • Xenon Pharmaceuticals
  • Zogenix